Company intelligence / Profile preview

Botanico

Herzliya, Israel

Ownership: Private
Development stage: Other

Overview

Botanico (ISHI) operates as a premium medical cannabis technology and brand company, delivering advanced cultivation technologies. Following its acquisition by InterCure in 2025, it provides immediate access to proprietary cultivation systems, American brand partnerships, and is designed to capitalize on regulatory changes in the U.S. cannabis market.

Therapeutic areas: Neurology
Modalities: Plant-derived therapiesCannabis (for medical use)
Industry: Agriculture & AgTech

Partnerships

Leading American cannabis operators

Beyond the preview

Go deeper on Botanico.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Botanico.

Explore the full profile